Key takeaways The FDA approved the first generic GLP-1 specifically indicated for weight loss, a version of the popular injectable medication, Saxenda
similarly, in the pulmonary circulation, endothelial dysfunction has been identified as an early event leading to the development of pulmonary hypertension in the context of experimental heart failure [21]
There is no guarantee that these products contain what they claim
[1] [2] Native GLP-1 is broken down within minutes by an enzyme called DPP-4, which is precisely why pharmaceutical GLP-1 receptor agonists were engineered to resist that breakdown and last far longer
Furthermore, women with nephrotic range proteinuria should be prescribed prophylactic low-molecular-weight heparin to mitigate venous thromboembolism risk
At each step in the shared decision-making process, clinicians need to identify a motivation for the patient to lose weight, according to Barbara Eichorst, MS, RD, CDCES, vice president of health care programs at the American Diabetes Association